•  
  •  
  •  
  •  

2025-08-08 21:51:32

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  CLEducate

Stock Report

  • CL Educate Ltd Q4 FY2025 consolidated loss at Rs. 15.72 crores
  • CL Educate Ltd to acquire Digital Examination Business of NSEIT Ltd
  • CL Educate Ltd Q4 FY24 consolidated net profit at Rs. 1.14 crore
  • CL Educate increases stake to 39 percent in 361 Degree Minds, India's first OPM Company
  • CL Educate Ltd reports consolidated PAT of Rs. 5.48 crores in Q2 FY24
  • CL Educate Ltd consolidated Q1FY24 PAT up QoQ at Rs. 5.47 crore
  • CL Educate Ltd reports consolidated PAT of Rs. 4.01 crore in Q3FY23
  • CL Educate Ltd allots 2,75,34,156 bonus equity shares
  • CL Educate Ltd fixes Dec 16, 2022 as record date for 1:1 bonus issue
  • CL Educate Ltd Board recommends 1:1 Bonus Issue
  • CL Educate Ltd Q2FY23 consolidated PAT at Rs. 4.40 crores
  • CL Educate Ltd Board to consider Bonus Issue
  • CL Educate Ltd reports consolidated net profit of Rs. 11.86 crores
  • CL Educate reports consolidated PAT of Rs. 4.56 crores in Q4FY22
  • CL Educate Limited to sell Greater Noida campus for Rs. 48 crores
  • CL Educate sells Greater Noida campus, to receive INR 48 crores
  • CL Educate posts consolidated PAT at Rs. 3.08 crore
  • CL Educate liquidates third land parcel this year
  • CL Educate Ltd Q2FY22 consolidated PAT at Rs. 3.28 crore
  • CL Educate liquidates land parcels, will deploy cash in Business
  • CL Educate centres reopen with a bang post COVID

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024